ARCHIVE

• R&D NEWS IN BRIEF
  July 11, 2005

• Eisai to Expand Independent Marketing System in Europe
  July 11, 2005

• MEDICAL DEVICE NEWS IN BRIEF
  July 11, 2005

• Sankyo Spends Most Time on Shareholders' Meetings
  July 11, 2005

• Societies Agree to Introduce Unified Cancer Specialist Certification System
  July 11, 2005

• Mr Murakami Stresses Need for Daiichi Sankyo to Boost Share Price
  July 11, 2005

• REGULATORY NEWS IN BRIEF
  July 11, 2005

• Sankyo's Shareholders Approve Integration with Daiichi
  July 11, 2005

• NDA Review Delayed in 2004: OPIR News
  July 11, 2005

• STATISTICS
  July 11, 2005

• Study Group on Clinical Trials Holds 4th Meeting
  July 11, 2005

• SURVEY 2 articles
  July 11, 2005

• Discussions to Center on Low-priced Old Drugs, Price Adjustment Based on Overseas Prices
  July 11, 2005

• Clinical Trial Registration/Announcement System Started Operation on July 1
  July 11, 2005

• JGPMA Formally Accepted as Observer at IGPA
  July 4, 2005

• JCR Pharmaceuticals Expects to Launch Generic EPO in 2009 or 2010
  July 4, 2005

• Blopress Is Japan's Top-selling Drug; Mevalotin Falls to 3rd
  July 4, 2005

• REGULATORY NEWS IN BRIEF
  July 4, 2005

• Basic Policy 2005 for Economic/Fiscal Management and Structural Reform Approved
  July 4, 2005

• Common IRB Proposed in Special Regulatory Reform Zone in Osaka
  July 4, 2005

ページ

• « 先頭
• ‹ Prev
• …
• 457
• 458
• 459
• 460
• 461
• 462
• 463
• 464
• 465
• …
• Next ›
• 最終 »